To determine the current incidence of hepatitis B core antibody (anti-HBc) in a healthy blood donor population, 1,893 donors were screened for anti-HBc. Forty-one (2.16%) were found to be initially positive and 35 (1.85%) repeatably positive. Sera from the repeatably positive donors were further scr
Hepatitis B core antibody in volunteer blood donors: Comparison of radioimmunoassay and indirect immunofluorescence
✍ Scribed by Dr. J. N. Katchaki; T. H. Siem; R. Brouwer
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 335 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The results of a pilot study on the prevalence of anti‐HBc in HBsAg negative volunteer blood donors are presented.
Two techniques for anti‐HBc determination were compared — radio—immunoassay (RIA) and indirect immunofluorescence (IF). In a panel of 56 sera with known HBV markers, RIA was found to be significantly more sensitive than IF, and both techniques were specific. Out of 2,000 HBsAg negative blood donor sera tested by RIA,46 (2.3%) were found positive for anti‐HBc. In 24/24 sera, the specificity of the anti‐HBc was confirmed. Also 37/46 (80.4%) anti‐HBc positives were found positive for anti‐HBs, leaving 9/2, OOC (0.4%) blood donors positive only for anti‐HBc.
It is concluded that it would be premature to advocate the introduction of anti‐HBc as a routine screening test of blood donors.
📜 SIMILAR VOLUMES
Approximately 90% of subjects with chronic hepatitis resulting from hepatitis C virus infection have hepatitis C virus RNA in serum. However, the prevalence of hepatitis C virus RNA in serum from subjects with hepatitis C virus antibody associated with persistent normal liver biochemical values is u
## Abstract It is not known whether there is a trend of increasing or decreasing incidence of new hepatitis C virus (HCV) infections in Japan. From the treatment point of view, it is important to verify HCV genotypes and the prevalence of treatment‐resistant clones of HCV. At the Japanese Red Cross
## Abstract Of 103,203 donations collected in Scotland and Northern Ireland over a 3‐month period and screened for HCV antibody by Ortho or Abbott second‐generation ELISAs, 340 were found repeatedly reactive. Supplementary testing with RIBA‐2 resulted in 77 being classified as positive, 130 as inde
## Abstract A solid‐phase radioimmunoassay (RIA) for IgM anti‐HBc is described. The assay (anti‐m̈ RIA) is based on the adsorption of IgM to a tube coated with sheep antibody to the human IgM m̈‐chain. The adsorbed immunoglobulin is assayed for anti‐HBc activity. Positive reactions in the test are
Anti-HBc IgM was determined by a modified radioimmunoassay (RIA) in 35 patients with acute hepatitis B, 35 patients with chronic hepatitis B (7 with chronic persistent, and 28 with chronic active hepatitis), 157 HBsAg positive blood donors, and in 143 HBsAg negative but anti-HBc positive donors. The